Literature DB >> 14603340

Kinetics of proviral DNA load, soluble interleukin-2 receptor level and tax expression in patients with adult T-cell leukemia receiving allogeneic stem cell transplantation.

M Hishizawa, K Imada, T Ishikawa, T Uchiyama.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14603340     DOI: 10.1038/sj.leu.2403204

Source DB:  PubMed          Journal:  Leukemia        ISSN: 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  6 in total

1.  Antibody responses associated with the graft-versus-leukemia effect in adult T-cell leukemia.

Authors:  Masakatsu Hishizawa; Kazunori Imada; Tomomi Sakai; Momoko Nishikori; Nobuyoshi Arima; Mitsuru Tsudo; Takayuki Ishikawa; Takashi Uchiyama
Journal:  Int J Hematol       Date:  2006-05       Impact factor: 2.490

2.  Case of a patient with progressive adult T-cell leukemia/lymphoma treated successfully by reduced-intensity conditioning stem cell transplantation from an HLA-incompatible related donor.

Authors:  Hiroshi Fujiwara; Hideaki Kawada; Kakushi Matsushita; Heiichiro Hamada; Atsuo Ozaki; Hirosaka Inoue; Makoto Yoshimitsu; Toshimasa Kukita; Kosei Arimura; Hideo Ohtsubo; Kimiharu Uozumi; Naomichi Arima; Chuwa Tei
Journal:  Int J Hematol       Date:  2005-11       Impact factor: 2.490

3.  Long-term follow-up of HTLV-1 proviral load in asymptomatic carriers and in incident cases of HAM/TSP: what is its relevance as a prognostic marker for neurologic disease?

Authors:  Marina Lobato Martins; Jacqueline Cronemberger Guimarães; João Gabriel Ribas; Luiz Cláudio Ferreira Romanelli; Anna Bárbara de Freitas Carneiro-Proietti
Journal:  J Neurovirol       Date:  2016-09-27       Impact factor: 2.643

4.  Human T-cell leukemia virus type 1 expressing nonoverlapping tax and rex genes replicates and immortalizes primary human T lymphocytes but fails to replicate and persist in vivo.

Authors:  Ihab Younis; Brenda Yamamoto; Andrew Phipps; Patrick L Green
Journal:  J Virol       Date:  2005-12       Impact factor: 5.103

5.  Durable hematologic complete response and suppression of HTLV-1 viral load following alemtuzumab in zidovudine/IFN-{alpha}-refractory adult T-cell leukemia.

Authors:  Andrew Mone; Shannon Puhalla; Susan Whitman; Robert A Baiocchi; Julio Cruz; Tamara Vukosavljevic; Amy Banks; Charles F Eisenbeis; John C Byrd; Michael A Caligiuri; Pierluigi Porcu
Journal:  Blood       Date:  2005-08-02       Impact factor: 22.113

6.  APOBEC3G targets human T-cell leukemia virus type 1.

Authors:  Amane Sasada; Akifumi Takaori-Kondo; Kotaro Shirakawa; Masayuki Kobayashi; Aierkin Abudu; Masakatsu Hishizawa; Kazunori Imada; Yuetsu Tanaka; Takashi Uchiyama
Journal:  Retrovirology       Date:  2005-05-19       Impact factor: 4.602

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.